Products

What will AGI do for Balsalazide?

This classification denotes a nonsteroidal antiinflammatory drug, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier P80AL8J7ZP. European Medicines Agency schedules Balsalazide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06092MIG. Balsalazide generally arises in the molecular formula C17H15N3O6. The term BALSALAZIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 37, no. 6, 1983, list 23.) BALSALAZIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule balsalazide under HS 29270000 and SITC 51485. As of Q4 2014, BALSALAZIDE remains the US FDA Preferred Term for this commodity. Balsalazide bears US NLM identifiers UMLS ID C0052940 and NCI Concept Code C65247. SMILES: O=C(NCCC(=O)O)C1CCC(N/N=C2/C=C(C(=O)C=C2)C(=O)O)CC1.

How AGI delivers it

Four ways AGI delivers for Balsalazide

  • Headless SaaS for Agents

    Give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

    For Balsalazide, give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

  • Services-as-Software

    Get the professional outcome delivered as software, priced on results, not headcount.

    For Balsalazide, get the professional outcome delivered as software, priced on results, not headcount.

Value flow

How Balsalazide connects

measured by

  • Assaymodel
  • Assay Puritymodel
  • Chromatographic Impurity Profilemodel
  • Moisture Contentmodel
  • Particle Size Distributionmodel
  • Puritymodel